Medprin Regenerative Medical Technologies Co. Ltd. - Asset Resilience Ratio

Latest as of June 2025: 19.31%

Medprin Regenerative Medical Technologies Co. Ltd. (301033) has an Asset Resilience Ratio of 19.31% as of June 2025. The Asset Resilience Ratio measures the percentage of a company's total assets that are held in liquid form (cash and short-term investments). This metric indicates how well-positioned the company is to handle unexpected financial challenges, economic downturns, or strategic opportunities without requiring external financing. See how financially flexible is Medprin Regenerative Medical Technologie to measure the company's free cash flow as a share of total liabilities.

Liquid Assets

CN¥155.45 Million

≈ $22.75 Million USD Cash + Short-term Investments

Total Assets

CN¥805.10 Million

≈ $117.81 Million USD All company assets

Resilience Assessment

Good

Financial Resilience Level

Asset Resilience Ratio Trend (2019–2024)

This chart shows how Medprin Regenerative Medical Technologies Co. Ltd.'s Asset Resilience Ratio has changed over time. See how leveraged is Medprin Regenerative Medical Technologie's balance sheet to measure how much of total assets are equity-financed.

Liquid Assets Composition Over Time

This chart breaks down Medprin Regenerative Medical Technologies Co. Ltd.'s liquid assets into cash & equivalents and short-term investments, showing how the composition has evolved over time. For market capitalisation and broader financial context, see Medprin Regenerative Medical Technologie market cap and net worth.

Current Liquid Assets Breakdown

Component	Amount	% of Total Assets
Cash & Equivalents	CN¥0.00	0%
Short-term Investments	CN¥155.45 Million	19.31%
Total Liquid Assets	CN¥155.45 Million	19.31%

Asset Resilience Insights

Good Liquidity Position: Medprin Regenerative Medical Technologies Co. Ltd. maintains a healthy 19.31% of assets in liquid form.
This level provides good financial flexibility while maintaining productive asset deployment.
The company has significant short-term investments, indicating active treasury management.

Medprin Regenerative Medical Technologies Co. Ltd. Industry Peers by Asset Resilience Ratio

Compare Medprin Regenerative Medical Technologies Co. Ltd.'s asset resilience ratio with other companies in the same industry.

Company	Industry	Asset Resilience Ratio
Medacta Group SA SW:MOVE	Medical Devices	0.86%
Double Medical Technology Inc SHE:002901	Medical Devices	12.59%
Shenzhen New Industries Biomedical SHE:300832	Medical Devices	9.95%
Jafron Biomedical Co Ltd SHE:300529	Medical Devices	39.15%
Sinocare Inc SHE:300298	Medical Devices	3.53%
Xiangyu Medical Co. Ltd. A SHG:688626	Medical Devices	1.53%
INKON Life Technology Co Ltd SHE:300143	Medical Devices	5.73%
HOB Biotech Group Corp Ltd SHG:688656	Medical Devices	2.62%

Annual Asset Resilience Ratio for Medprin Regenerative Medical Technologies Co. Ltd. (2019–2024)

The table below shows the annual Asset Resilience Ratio data for Medprin Regenerative Medical Technologies Co. Ltd..

Year	Asset Resilience Ratio (%)	Liquid Assets	Total Assets	Change
2024-12-31	17.25%	CN¥137.85 Million ≈ $20.17 Million	CN¥799.23 Million ≈ $116.95 Million	-7.25pp
2023-12-31	24.50%	CN¥192.82 Million ≈ $28.22 Million	CN¥786.97 Million ≈ $115.16 Million	+4.76pp
2022-12-31	19.74%	CN¥147.07 Million ≈ $21.52 Million	CN¥744.92 Million ≈ $109.01 Million	-30.55pp
2021-12-31	50.29%	CN¥375.57 Million ≈ $54.96 Million	CN¥746.78 Million ≈ $109.28 Million	+6.51pp
2020-12-31	43.78%	CN¥199.33 Million ≈ $29.17 Million	CN¥455.34 Million ≈ $66.63 Million	-1.15pp
2019-12-31	44.93%	CN¥152.77 Million ≈ $22.36 Million	CN¥340.05 Million ≈ $49.76 Million	--

pp = percentage points

About Medprin Regenerative Medical Technologies Co. Ltd.

SHE:301033 China Medical Devices

Market Cap

$479.78 Million

CN¥3.28 Billion CNY

Market Cap Rank

#12618 Global

#3728 in China

Share Price

CN¥48.90

Change (1 day)

+1.03%

52-Week Range

CN¥45.77 - CN¥88.80

All Time High

CN¥88.80